ArticleCurrent oncology (Toronto, Ont.)2021

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome.

Sim Vermeulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.